• Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies.
  Alam, J. J., Maruff, P., Doctrow, S. R., Chu, H. M., Conway, J., Gomperts, S. N., & Teunissen, C.
  Neurology. 2023;101(17):e1708-e1717. doi:10.1212/WNL.0000000000207755
• Optogenetic targeting of astrocytes restores slow brain rhythm function and slows Alzheimer’s disease pathology.
  Lee, Y. F., Russ, A. N., Zhao, Q., Perle, S. J., Maci, M., Miller, M. R., Hou, S. S., Algamal, M., Zhao, Z., Li, H., Gelwan, N., Liu, Z., Gomperts, S. N., Araque, A., Galea, E., Bacskai, B. J., & Kastanenka, K. V.
  Sci Rep. 2023;13(1):13075. Published 2023 Aug 11. doi:10.1038/s41598-023-40402-3
• Disruption of hippocampal neuronal circuit function depends upon behavioral state in the APP/PS1 mouse model of Alzheimer’s disease.
  Heng Zhou, Hanyan Li, Niket Gowravaram, Moqin Quan, Naila Kausar, Stephen N Gomperts
  Sci Rep. 2022;12(1):21022. Published 2022 Dec 5. doi:10.1038/s41598-022-25364-2
• 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome
  Goodheart AE, Locascio JJ, Samore WR, Collins JA, Brickhouse M, Schultz A, Touroutoglou A, Johnson KA, Frosch MP, Growdon JH, Dickerson BC, Gomperts SN.
  Nat Commun. 2022 Sep 21;13(1):5308. doi: 10.1038/s41467-022-32944-3.
• Serum NFL levels predict progression of motor impairment and reduction in putamen dopamine transporter binding ratios in de novo Parkinson’s disease: An 8-year longitudinal study
  Ye R, Locascio JJ, Goodheart AE, Quan M, Zhang B, Gomperts SN.
  Parkinsonism Relat Disord. 2021 Apr;85:11-16. doi: 10.1016/j.parkreldis.2021.02.008. Epub 2021 Feb 17.
• Topography of cortical thinning in the Lewy body diseases.
  Ye R, Touroutoglou A, Brickhouse M, Katz S, Growdon JH, Johnson KA, Dickerson BC, Gomperts SN.
  Neuroimage Clin. 2020;26:102196. doi: 10.1016/j.nicl.2020.102196. Epub 2020 Jan 31.
• Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
  Shirvan J, Clement N, Ye R, Katz S, Schultz A, Johnson KA, Gomez-Isla T, Frosch M, Growdon JH, Gomperts SN.
  Neurology. 2019 Jul 30;93(5):e476-e484. doi: 10.1212/WNL.0000000000007855. Epub 2019 Jun 26.
• Cholinergic modulation of hippocampal calcium activity across the sleep-wake cycle.
  Zhou H, Neville KR, Goldstein N, Kabu S, Kausar N, Ye R, Nguyen TT, Gelwan N, Hyman BT, Gomperts SN.
  Elife. 2019 Mar 7;8:e39777. doi: 10.7554/eLife.39777.
• Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.
  Gomperts SN, Locascio JJ, Makaretz SJ, Schultz A, Caso C, Vasdev N, Sperling R, Growdon JH, Dickerson BC, Johnson K.
  JAMA Neurol. 2016 Nov 1;73(11):1334-1341. doi: 10.1001/jamaneurol.2016.3338.
• Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
  Gomperts SN, Locascio JJ, Rentz D, Santarlasci A, Marquie M, Johnson KA, Growdon JH.
  Neurology. 2013 Jan 1;80(1):85-91. doi: 10.1212/WNL.0b013e31827b1a07. Epub 2012 Dec 12.